Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders [Phase 1, Phase 2]
Phase I/II trial of AD-PluReceptor plus tafasitamab-cxix with lymphodepleting chemotherapy in autoimmune disorders is currently recruiting, …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Immun4Cure Cohort of Autoimmune Diseases
Clinical trial update from University Hospital, Montpellier on the Immun4Cure cohort for autoimmune diseases (Rheumatoid Arthritis and Syste…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Patient-Centered Assessment of Symptoms and Outcomes
NCCIH-sponsored clinical trial update describes a study on patient-centered assessment of symptoms and outcomes for fatigue and cancer, curr…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial assessing safety and immunogenicity of the live attenuated tetravalent Butantan-Dengue vaccine in autoimmune rheumati…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase I Study to Assess LBL-047 in Healthy Adults and Patients With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 trial to assess the safety, tolerability, and pharmacokinetics of LBL-047 in healthy adults and in patients with Systemic lupus er…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of CC312 for Relapsed/Refractory Autoimmune Diseases [EARLY_Phase 1]
This is an early-phase 1 study evaluating CC312 for relapsed/refractory autoimmune diseases, including systemic lupus erythematosus, idiopat…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus [Phase 3]
Nipocalimab is being studied in a Phase 3 trial for adults with moderate to severe systemic lupus erythematosus and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
A Bristol-Myers Squibb-sponsored clinical trial is recruiting participants with active systemic lupus erythematosus who have inadequate resp…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users [Phase 4]
This Phase 4 clinical trial registry is evaluating maternal, infant, and lactation outcomes in patients using anifrolumab for systemic lupus…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs） [Phase 1]
Phase 1 trial update showing that HN2301 is being studied for autoimmune diseases with ongoing recruitment, including systemic lupus erythem…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus [Phase 1]
A first-in-human Phase 1 trial is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7507062 in participants w…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Lupus Intervention for Fatigue Trial [NA]
A clinical trial update for NCT02653287 describes an intervention aimed at reducing fatigue in systemic lupus erythematosus. The study is cu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Lupus Walking Intervention to Address Fatigue/Quality of Life [NA]
A completed clinical trial update focusing on a walking intervention to address fatigue and quality of life in systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus
A real-world study evaluating the outcomes of anifrolumab for systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine Care
A non-interventional study (NIS) is recruiting to examine disease activity in systemic lupus erythematosus patients treated with subcutaneou…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus [Phase 1, Phase 2]
A Phase 1/2 open-label study evaluating the safety and efficacy of CABA-201 in active systemic lupus erythematosus (including lupus nephriti…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE [Phase 1, Phase 2]
This clinical trial update describes the study of AZD0120 in adults with refractory systemic lupus erythematosus, spanning Phase 1 and Phase…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus
International prospective study update assessing adherence to treatment in patients with active systemic lupus erythematosus.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: CHT105 for the Treatment of Refractory Lupus Nephritis [NA]
Clinical trial update for CHT105 evaluating its use in refractory lupus nephritis; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus [Phase 1, Phase 2]
This entry reports that a Phase 1/2 study evaluating GC012F injection for refractory systemic lupus erythematosus is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease [Phase 1]
Phase 1 clinical trial update for ALLO-329, an allogeneic CAR T-cell therapy, in adults with autoimmune diseases including systemic lupus er…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of E6742 in Participants With Systemic Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial evaluating E6742 for systemic lupus erythematosus is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Universal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]
Early-phase trial update for CHT101, a universal anti-CD70 CAR-T cell therapy for relapsed/refractory systemic lupus erythematosus; the stud…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus [Phase 3]
This update describes a Phase 3 clinical trial evaluating obinutuzumab for systemic lupus erythematosus, with study status currently active …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
Clinical trial update describing the development of a therapeutic endpoint for pediatric rheumatologic conditions. Recruitment is underway f…